Sandra Cvijić

University of Belgrade

H指数:19

被引数:976

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of aripiprazole precipitation during simulated gastric to intestinal transfer in the glass-bead flow through in vitro system

在玻璃珠流动通过体外系统中模拟胃至肠道转移过程中阿立哌唑沉淀的表征

Journal of Drug Delivery Science and Technology

IF4.9

2026-10-220

PRE

Patient-centric dissolution testing for oral drug products: From disease-specific gastrointestinal physiology to biopredictive in vitro methods

以患者为中心的口服药物产品溶出度测试：从疾病特异性胃肠道生理学到生物预测性体外方法

Journal of Drug Delivery Science and Technology

IF4.9

2026-08-010

PRE

Advancing Pharmacoequity in Low- and Middle-Income Countries via Model Informed Drug Development

通过模型告知药物开发推动中低收入国家的药物可及性

Clinical and Translational Science

IF2.8

2026-04-270

Simulation-guided dissolution testing: Coupling DDDPlus™ and GastroPlus® to predict aripiprazole oral bioperformance

仿真指导的溶出度测试：耦合DDDPlus™和GastroPlus®以预测阿立哌唑口服生物利用度

Journal of Drug Delivery Science and Technology

IF4.9

2025-10-090

PRE

Physiologically Based Pharmacokinetic Modeling of Hydroxyurea: Implications for Dose Adjustment in Patients with Renal Insufficiency

基于生理的药代动力学模型在羟基脲中的应用：肾功能不全患者剂量调整的启示

Journal of Pharmaceutical Sciences

IF3.8

2025-09-230

PRE

In Vitro-In Silico Approach in the Development of Clopidogrel Solid Dispersion Formulations

体外-计算机模拟方法在氯吡格雷固体分散体处方开发中的应用

BIOENGINEERING-BASEL

IF3.7

2025-03-300

Erectile Dysfunction Therapy of Bariatric Patients: Tadalafil Biopharmaceutics and Pharmacokinetics Before vs. After Gastric Sleeve/Bypass

AAPS JOURNAL

IF3.7

2024-11-140

Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration

PHARMACEUTICALS

IF4.8

2024-01-301

OAAI

The Complexity of Bariatric Patient's Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/Bypass

PHARMACEUTICS

IF5.5

2023-12-182

OAAI

Selective COX-2 inhibitors after bariatric surgery: Celecoxib, etoricoxib and etodolac post-bariatric solubility/dissolution and pharmacokinetics

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2023-10-017

PRE

In Vitro and In Vivo Evaluation of Inhalable Ciprofloxacin Sustained Release Formulations

PHARMACEUTICS

IF5.5

2023-09-064

OAAI

Evaluating the pharmacokinetics of intrapulmonary administered ciprofloxacin solution for respiratory infections using in vivo and in silico PBPK rat model studies

CHINESE CHEMICAL LETTERS

IF8.9

2023-01-015

PRE

In-Depth Analysis of Physiologically Based Pharmacokinetic (PBPK) Modeling Utilization in Different Application Fields Using Text Mining Tools

使用文本挖掘工具深入分析不同应用领域的基于生理的药代动力学 (PBPK) 建模利用

PHARMACEUTICS

IF5.5

2022-12-289

OAAI

Numerical Modeling of Particle Dynamics Inside a Dry Powder Inhaler

PHARMACEUTICS

IF5.5

2022-11-240

OAAI

The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil

PHARMACEUTICS

IF5.5

2022-06-276

OAAI

3D Printed Buccal Films for Prolonged-Release of Propranolol Hydrochloride: Development, Characterization and Bioavailability Prediction

PHARMACEUTICS

IF5.5

2021-12-1325

OAAI

The evaluation of the effect of different superdisintegrants on the drug release from FDM 3D printed tablets through different applied strategies: In vitro-in silico assessment

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2021-12-0124

PRE

Mucoadhesive buccal tablets with propranolol hydrochloride: Formulation development and in vivo performances in experimental essential hypertension

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2021-12-016

PREAI

Comparative Assessment of In Vitro and In Silico Methods for Aerodynamic Characterization of Powders for Inhalation

PHARMACEUTICS

IF5.5

2021-11-025

OAAI

Application of Machine-Learning Algorithms for Better Understanding of Tableting Properties of Lactose Co-Processed with Lipid Excipients

PHARMACEUTICS

IF5.5

2021-05-0517

OAAI

Sandra Cvijić

个人简介

教育背景

工作经历

荣誉奖项

研究方向